Systemic Lupus Erythematosus Clinical Trials in Bethesda, Maryland

4 studies are recruiting for systemic lupus erythematosus in Bethesda, Maryland right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD

    Background: People with systemic lupus erythematosus (SLE) are at risk of developing complications in their blood vessels. This can increase the risk of heart attacks or stroke. No medications have been effective at reducing this risk in people with lupus. Objective: To test whether a drug (anifrol…

    Stage
    Phase 2
    Ages
    18 to 80
    Site
    National Institutes of Health Clinical Center, Bethesda, Maryland
    Run by
    National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    See if you can join NCT05440422 on ClinicalTrials.gov

  2. Study of Systemic Lupus Erythematosus

    This protocol will evaluate patients with systemic lupus erythematosus (SLE) and their relatives to learn more about how the disease develops and changes over time. It will also study genetic factors that make a person susceptible to SLE. Patients 3 years of age and older with known or suspected SL…

    Stage
    Not phased
    Ages
    3 to 120
    Site
    National Institutes of Health Clinical Center, Bethesda, Maryland
    Run by
    National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    See if you can join NCT00001372 on ClinicalTrials.gov

  3. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    This phase Ib trial studies the side effects of nivolumab and to see how well it works alone and in combination with other treatments, such as ipilimumab, cabozantinib, platinum containing therapy, and fluoropyrimidine, in treating patients with autoimmune disorders and cancer that has spread from …

    Stage
    Phase 1
    Ages
    18 and older
    Site
    National Cancer Institute Developmental Therapeutics Clinic, Bethesda, Maryland
    Locations
    52 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT03816345 on ClinicalTrials.gov

  4. An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

    A Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), Efficacy, and Safety of Anifrolumab in Children with Moderate to Severe Active Systemic Lupus Erythematosus (SLE)

    Stage
    Phase 3
    Ages
    5 to 17
    Site
    Research Site, Bethesda, Maryland
    Locations
    103 in total
    Run by
    AstraZeneca

    See if you can join NCT05835310 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.